RECRUITINGOBSERVATIONAL
Complex Molecular Etiology and Cellular Landscape of Hip Osteoarthritis
Studies on the Complex Molecular Etiology and Cellular Landscape of Hip Osteoarthritis
About This Trial
The purpose of this study is to cast light on the highly complex etiology and cellular landscape of hip osteoarthritis by utilising single-cell and spatial omics.
Who May Be Eligible (Plain English)
Inclusion Criteria for the main (OA) study:
Cases: Adult patients with osteoarthritis in the hip joint and who are going through an elective total hip arthroplasty.
Controls: Non-arthritis adult patients who are going through a trauma-based emergency total hip arthroplasty.
\----
Inclusion Criteria for the Rheumatoid sub-study:
Adult patients with rheumatoid arthritis in the hip joint and who are going through an elective total hip arthroplasty.
\----
Who Should NOT Join This Trial:
- The body mass index must be below 35
- Age \< 18 or \> 74
- The OA patients may not have diabetes, rheumatoid arthritis (RA), or metabolic syndrome.
For the Rheumatoid sub-study, the exclusion criteria are the same as above except for the RA.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria for the main (OA) study:
Cases: Adult patients with osteoarthritis in the hip joint and who are going through an elective total hip arthroplasty.
Controls: Non-arthritis adult patients who are going through a trauma-based emergency total hip arthroplasty.
\----
Inclusion Criteria for the Rheumatoid sub-study:
Adult patients with rheumatoid arthritis in the hip joint and who are going through an elective total hip arthroplasty.
\----
Exclusion Criteria:
* The body mass index must be below 35
* Age \< 18 or \> 74
* The OA patients may not have diabetes, rheumatoid arthritis (RA), or metabolic syndrome.
For the Rheumatoid sub-study, the exclusion criteria are the same as above except for the RA.
Treatments Being Tested
PROCEDURE
Total hip arthroplasty
Hip joint replacement surgery. Elective for RA and OA cases.
Locations (4)
PET-centre, University of Turku
Turku, Southwest Finland, Finland
Turku Bioscience, University of Turku
Turku, Southwest Finland, Finland
Turku University Hospital
Turku, Southwest Finland, Finland
Helsinki University Hospital
Espoo, Uusimaa, Finland